CA985628A - Antibacterial compositions containing 2,4-diamino pyrimidine and rifampicin - Google Patents

Antibacterial compositions containing 2,4-diamino pyrimidine and rifampicin

Info

Publication number
CA985628A
CA985628A CA159,798A CA159798A CA985628A CA 985628 A CA985628 A CA 985628A CA 159798 A CA159798 A CA 159798A CA 985628 A CA985628 A CA 985628A
Authority
CA
Canada
Prior art keywords
rifampicin
compositions containing
antibacterial compositions
diamino pyrimidine
diamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA159,798A
Other languages
English (en)
Other versions
CA159798S (en
Inventor
Vittorio Arioli
Luigi Silvestri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA filed Critical Gruppo Lepetit SpA
Application granted granted Critical
Publication of CA985628A publication Critical patent/CA985628A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CA159,798A 1971-12-23 1972-12-22 Antibacterial compositions containing 2,4-diamino pyrimidine and rifampicin Expired CA985628A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT3283871 1971-12-23

Publications (1)

Publication Number Publication Date
CA985628A true CA985628A (en) 1976-03-16

Family

ID=11236012

Family Applications (1)

Application Number Title Priority Date Filing Date
CA159,798A Expired CA985628A (en) 1971-12-23 1972-12-22 Antibacterial compositions containing 2,4-diamino pyrimidine and rifampicin

Country Status (11)

Country Link
US (1) US3852450A (esLanguage)
JP (1) JPS535381B2 (esLanguage)
AU (1) AU466967B2 (esLanguage)
BE (1) BE793253A (esLanguage)
CA (1) CA985628A (esLanguage)
FR (1) FR2164856B1 (esLanguage)
GB (1) GB1346710A (esLanguage)
IE (1) IE37080B1 (esLanguage)
IL (1) IL41009A (esLanguage)
NL (1) NL152755B (esLanguage)
ZA (1) ZA728947B (esLanguage)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209513A (en) 1974-02-14 1980-06-24 Burroughs Wellcome Co. Tablet formulation
US4033962A (en) * 1975-06-26 1977-07-05 Hoffman-La Roche Inc. 2,4-Diamino-pyrimidine derivatives and processes
US4125610A (en) * 1977-07-27 1978-11-14 Bristol-Myers Company Antibacterial compositions
US4762836A (en) * 1983-02-02 1988-08-09 Eli Lilly And Company Aromatase inhibitors
WO1992008461A1 (en) * 1990-11-14 1992-05-29 Protos Corporation Specific inhibition of dihydrofolate reductase and compounds therefor
AU2002350212A1 (en) * 2001-11-20 2003-06-10 Dana Farber Cancer Institute Pharmaceutically active compounds and methods of use thereof
US8313760B2 (en) 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
ES2369640T3 (es) 2002-05-24 2011-12-02 Angiotech International Ag Composiciones y métodos para revestir implantes médicos.
JP7072898B2 (ja) * 2016-08-16 2022-05-23 ユニバーシティ オブ ロチェスター ポリミキシンb/トリメトプリム系の治療薬を含有する医薬組成物

Also Published As

Publication number Publication date
AU4960372A (en) 1974-06-06
AU466967B2 (en) 1975-11-13
FR2164856B1 (esLanguage) 1975-10-17
US3852450A (en) 1974-12-03
IL41009A0 (en) 1973-02-28
GB1346710A (en) 1974-02-13
NL7217354A (esLanguage) 1973-06-26
DE2259624B2 (de) 1975-10-23
JPS535381B2 (esLanguage) 1978-02-27
IL41009A (en) 1975-12-31
NL152755B (nl) 1977-04-15
JPS4868721A (esLanguage) 1973-09-19
FR2164856A1 (esLanguage) 1973-08-03
ZA728947B (en) 1973-09-26
DE2259624A1 (de) 1973-06-28
IE37080L (en) 1973-06-23
BE793253A (fr) 1973-04-16
IE37080B1 (en) 1977-04-27

Similar Documents

Publication Publication Date Title
AU465305B2 (en) Composition
CA985628A (en) Antibacterial compositions containing 2,4-diamino pyrimidine and rifampicin
CA989839A (en) 5-(3-iodopropargyloxy) pyrimidine
CA923215A (en) Methode de composition d'enregistrements
CA977350A (en) Halogeno-6-hydroxy-pyridone-(2) compounds, their manufacture and use
CA965254A (en) Herbicidal composition
CA967964A (en) 2,4-diamino-5-(3,4,5-triethoxybenzyl) pyrimidine
AU4190272A (en) 2,5-bis-substituted pyrimidines
CA967697A (en) Stabilized polymeric composition
CA1026338A (en) 2,4-diamino pyrimidines
CA968800A (en) 6-(p-formylaminophenyl)-4,5-dihydropyridazone-(3)
CA990288A (en) "2,6-dichloro-benzaldoxime-0-(s-triazinyl-(6))-ethers"
CA882705A (en) 5,8-dihydronaphthyloxy-amino-propanols and related compounds
CA871678A (en) Griseofulvin composition
CA883014A (en) Roll composition
AU3769272A (en) Polyolefine composition
CA887650A (en) 2,7-diamino-6-arylpyrido(2,3) pyrimidine derivatives
CA886005A (en) Pyrimidine derivatives and compositions containing them
CA882176A (en) Floor-care compositions and new triazine used therein
CA867383A (en) 2,4,5,6-tetrachloropyrimidine
CA880323A (en) Hexahydro-and octahydro-1,12-trimethyleneindolo (2,3-a) quinolizines
CA886605A (en) 2-halo-1,1,1,3,3-pentafluoropropanes
CA883794A (en) Stabilized enzyme-carrier composition
CA877310A (en) 1-aza-(2,3:5,6)-dibenzocycloheptadiene derivatives and compositions thereof
CA875569A (en) 3,3'-bis-2-pyrazolines